Page 3 - Johnson Services News Today

Antibody Therapy MarketOver the projected period, the antibody treatment market share is anticipated to rise at a consistent 13.4% CAGR. By 2033, the market is projected to have grown from its 2023 projection of US$ 235 billion to a valuation of US$ 824.0 billion. Since they offer tailored and targeted approaches to...

In this article, we will discuss the Top 20 fastest growing industries in the next 5 years: Predictions. Click to skip ahead and jump to the Top 5 fastest growing industries in the next 5 years: Predictions. When considering where to apply for your next job, it proves beneficial to inquire, “Which industries are experiencing […]

/PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global PARP Inhibitors Market Size, Share & Trends...

Dublin, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The "Asia Pacific Non Hodgkin Lymphoma Therapeutics Market Size, Share & Trends Analysis Report By Cell Type (B-Cell Lymphoma and T-Cell Lymphoma), By Therapy Type (Radiation Therapy, Chemotherapy, Targeted Therapy, and Others), By Country and Growth Forecast, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.The Asia Pacific Non Hodgkin Lymphoma Therapeutics Market would witness market growth of 9.3% CAGR during...

 Surgical Stapling Device MarketAccording to projections, the surgical stapling device market share would be worth US$3,977.40 million by 2023. By 2033, the market research study projects a rise of US$ 5,930.60 million. Over the course of the projected period, a CAGR of 4.10% is anticipated in the sales of surgical...

The Canada pharmaceutical market size and share is currently valued at USD 48.62 billion in 2023. It is anticipated to generate an estimated revenue of USD 88.11 billion by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 6.9% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024-2032. The key market players include AbbVie, AstraZeneca, Eli Lilly, F. Hoffmann-La Roche, GlaxoSmithKline, Johnson & John...

Visiongain has published a new report entitled Dermatological Drugs Market Report 2024-2034: Forecasts by Route of Administration (Topical, Oral,...

Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The

Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The

/PRNewswire/ -- The "Prevention and Treatment of Prostate Cancer: Technologies and Global Markets" report has been added to ResearchAndMarkets.coms offering....